You are here

  • Home
  • Archive
  • Volume 82, Issue 3
  • Correction: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
Free

https://doi.org/10.1136/ard-2022-223356corr1

Smolen JS, Landewé RBM, Bergstra SA, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis 2023;82:3–18.

The competing interests statement was erroneously omitted and is now included in the online version. This correction has not been made in print.

Linked Articles

  • Recommendation
    EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
    Josef S Smolen Robert B M Landewé Sytske Anne Bergstra Andreas Kerschbaumer Alexandre Sepriano Daniel Aletaha Roberto Caporali Christopher John Edwards Kimme L Hyrich Janet E Pope Savia de Souza Tanja A Stamm Tsutomu Takeuchi Patrick Verschueren Kevin L Winthrop Alejandro Balsa Joan M Bathon Maya H Buch Gerd R Burmester Frank Buttgereit Mario Humberto Cardiel Katerina Chatzidionysiou Catalin Codreanu Maurizio Cutolo Alfons A den Broeder Khadija El Aoufy Axel Finckh João Eurico Fonseca Jacques-Eric Gottenberg Espen A Haavardsholm Annamaria Iagnocco Kim Lauper Zhanguo Li Iain B McInnes Eduardo F Mysler Peter Nash Gyula Poor Gorica G Ristic Felice Rivellese Andrea Rubbert-Roth Hendrik Schulze-Koops Nikolay Stoilov Anja Strangfeld Annette van der Helm-van Mil Elsa van Duuren Theodora P M Vliet Vlieland René Westhovens Désirée van der Heijde
    Annals of the Rheumatic Diseases 2022; 82 3-18 Published Online First: 10 Nov 2022. doi: 10.1136/ard-2022-223356